Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(56%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
1
11%
Ph phase_2
1
11%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Completed(3)

Detailed Status

Recruiting5
Completed3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

completed333%
not_yet_recruiting111%
recruiting556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
9